B. Riley Research Analysts Lower Earnings Estimates for KYMR
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Investment analysts at B. Riley reduced their Q3 2025 earnings per share (EPS) estimates for shares of Kymera Therapeutics in a note issued to investors on Tuesday, June 3rd. B. Riley analyst K. Patel now expects that the company will post earnings of ($1.04) per share for […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Investment analysts at B. Riley reduced their Q3 2025 earnings per share (EPS) estimates for shares of Kymera Therapeutics in a note issued to investors on Tuesday, June 3rd. B. Riley analyst K. Patel now expects that the company will post earnings of ($1.04) per share for […]
